T47DKBLUC - Cell Line (ID:51091)
HMS LINCS ID: | 51091 |
Name: | T47DKBLUC |
Alternative Names: | T47D-KBluc |
LINCS ID: | LCL-2064 |
Alternative ID: | CLO_0037191 |
Parent Cell Line: | |
Reference Source: | ATCC CRL-2865 |
Organism: | Homo sapiens |
Organ: | breast |
Tissue: | |
Cell Type: | |
Details of Cell Type: | |
Donor Sex: | |
Donor Age: | |
Donor Ethnicity: | |
Donor Health Status: | |
Disease: | |
Details of Disease: | |
Production Details: | The parent cell line was transfected with pGL2.TATA.Inr.luc.neo which contains three estrogen responsive elements upstream of a luc reporter gene. The cells were selected for responsiveness to 17-beta-estradiol. |
Genetic Modification(s): | pGL2.TATA.Inr.luc.neo integration |
Known Mutations: | |
Citation Information for Mutations: | |
Verification Reference Profile: | |
Growth Properties: | adherent |
Recommended Culture Conditions: | |
Relevant Citations: | |
Usage Note: | |
Comments: | |
Date Publicly Available: | 2013-07-30 |
Most Recent Update: | 2016-07-12 |
Datasets:
HMS Dataset ID | Dataset Title | HMS Dataset Type |
---|---|---|
20120 | Metrics other than potency reveal systematic variation in responses to cancer drugs | Analysis |
20268 | Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. | Analysis |
20269 | Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. | Analysis |
Batch Information:
HMS LINCS Batch ID | Provider | Provider Catalog ID | Provider Batch ID |
---|---|---|---|
51091-1 | ATCC | CRL-2865 |